RETRACTED: Ferroportin in the progression and prognosis of hepatocellular carcinoma (Q37426500)

From Wikidata

Jump to navigation Jump to search

retracted scientific article published on 20 December 2013

Ferroportin in the progression and prognosis of hepatocellular carcinoma

Language	Label	Description	Also known as
English	RETRACTED: Ferroportin in the progression and prognosis of hepatocellular carcinoma	retracted scientific article published on 20 December 2013	Ferroportin in the progression and prognosis of hepatocellular carcinoma

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

RETRACTED: Ferroportin in the progression and prognosis of hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

author name string

Qin Wang

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Jun Zhou

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Dewu Zhong

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Qunwei Wang

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Jiangsheng Huang

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

20 December 2013

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

European Journal of Medical Research

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

18

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

59

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Retraction note: Ferroportin in the progression and prognosis of hepatocellular carcinoma

0 references

Essential but toxic: controlling the flux of iron in the body.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Unraveling Mechanisms Regulating Systemic Iron Homeostasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Ironing Out Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Ferroportin and hepcidin: a new hope in diagnosis, prognosis, and therapy for breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Ferroportin and iron regulation in breast cancer progression and prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Tumorigenic properties of iron regulatory protein 2 (IRP2) mediated by its specific 73-amino acids insert

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Investigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Overexpression of iron regulatory protein 1 suppresses growth of tumor xenografts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Global cancer statistics, 2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Iron chelators in cancer chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Estimating the world cancer burden: Globocan 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

A novel mammalian iron-regulated protein involved in intracellular iron metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

23 August 2017

Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

6 September 2017

Comparative studies of duodenal and macrophage ferroportin proteins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

14 September 2017

Dietary iron enhances the tumor rate in dimethylhydrazine-induced colon carcinogenesis in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

26 June 2018

Iron as a synergist for hepatocellular carcinoma induced by polychlorinated biphenyls in Ah-responsive C57BL/10ScSn mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

26 June 2018

Iron enhances tumor growth. Observation on spontaneous mammary tumors in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

26 June 2018

Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

2 September 2018

Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

2 September 2018

Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3878504

2 September 2018

Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/24360312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continual presence of oxygen and iron required for mammalian ribonucleotide reduction: Possible regulation mechanism

1 reference

https://pubmed.ncbi.nlm.nih.gov/24360312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24360312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of iron regulatory genes in a rat model of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24360312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1186/2047-783X-18-59

Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1186/2047-783X-18-59

Identifiers

10.1186/2047-783X-18-59

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37426500&oldid=2200349376"